MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

IntelliPharmaCeutics Intl Company Profile (NASDAQ:IPCI)

Consensus Ratings for IntelliPharmaCeutics Intl (NASDAQ:IPCI) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.67 (428.46% upside)

Analysts' Ratings History for IntelliPharmaCeutics Intl (NASDAQ:IPCI)
Show:
DateFirmActionRatingPrice TargetActions
12/31/2015Maxim GroupLower Price TargetBuy$8.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2015MackieSet Price TargetBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/9/2015Brean CapitalReiterated RatingBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2015NomuraDowngradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha